14329

    532815

    SMSPHARMA

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    SMS PHARMACEUTICALS LTD. Share Price Today

    SMS PHARMACEUTICALS LTD. is currently trading at ₹421.45, up by ₹3.8 from the previous close. The stock touched an intraday high of ₹424.80 and a low of ₹413.25 during the latest trading session. Over the past one year, SMS PHARMACEUTICALS LTD. has delivered a return of 74.73%, while the stock has gained 18.21% in the last one month.

    SMS PHARMACEUTICALS LTD. performance

    Today’s low Today’s high
    ₹ 413.25 ₹ 424.80
    ₹ 421.45
    52 week low 52 week high
    ₹ 207.99 ₹ 447.80
    ₹ 421.45
    Open Price ₹ 420.10
    Prev. Close ₹ 417.65
    Volume (Shares) 174002.00
    Total traded value ₹ 733.33
    Upper Circuit ₹ 501.15
    Lower Circuit ₹ 334.15
    info

    Investment Returns

    Over 1 Month 18.21% Over 3 Months 7.91% Over 6 Months 25.54% Over 1 Year 74.73%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    SMS PHARMACEUTICALS LTD. fundamentals


    • Market cap (Cr) 3,947.00
    • P/E Ratio (TTM) 45.09
    • Beta 1.27
    • Book Value / share 85.93
    • Return on equity 11.00%
    • EPS (TTM) 9.35
    • Dividend yield 0.09%
    • Net profit/quarter (Cr) 20.92
    info icon alternate text
    • Market cap (Cr) 3,947.90
    • P/E Ratio (TTM) 45.09
    • Beta 1.09
    • Book Value / share 85.93
    • Return on equity 11.00%
    • EPS (TTM) 9.35
    • Dividend yield 0.09%
    • Net profit/quarter (Cr) 20.92
    info icon alternate text

    SMS PHARMACEUTICALS LTD. Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 237.95
    Operating Expense 213.48
    Net Profit 20.92
    Net Profit Margin (%) 8.79
    Earnings Per Share (EPS) 2.29
    EBITDA 42.46
    Effective Tax Rate (%) 22.62
    Particulars DEC 2025 (Values in Cr)
    Revenue 210.45
    Operating Expense 182.89
    Net Profit 23.34
    Net Profit Margin (%) 11.09
    Earnings Per Share (EPS) 2.57
    EBITDA 47.55
    Effective Tax Rate (%) 25.45
    Particulars SEP 2025 (Values in Cr)
    Revenue 242.43
    Operating Expense 209.81
    Net Profit 25.14
    Net Profit Margin (%) 10.37
    Earnings Per Share (EPS) 2.82
    EBITDA 49.82
    Effective Tax Rate (%) 26.15
    Particulars JUN 2025 (Values in Cr)
    Revenue 196.05
    Operating Expense 172.78
    Net Profit 18.21
    Net Profit Margin (%) 9.28
    Earnings Per Share (EPS) 2.05
    EBITDA 39.45
    Effective Tax Rate (%) 23.67
    Particulars MAR 2025 (Values in Cr)
    Revenue 248.20
    Operating Expense 220.56
    Net Profit 20.62
    Net Profit Margin (%) 8.30
    Earnings Per Share (EPS) 2.43
    EBITDA 42.76
    Effective Tax Rate (%) 29.04
    Particulars MAR 2026 (Values in Cr)
    Revenue 886.87
    Operating Expense 778.96
    Net Profit 87.61
    Net Profit Margin (%) 9.87
    Earnings Per Share (EPS) 9.58
    EBITDA 179.26
    Effective Tax Rate (%) 24.64
    Particulars MAR 2025 (Values in Cr)
    Revenue 782.75
    Operating Expense 695.65
    Net Profit 68.38
    Net Profit Margin (%) 8.73
    Earnings Per Share (EPS) 8.07
    EBITDA 146.20
    Effective Tax Rate (%) 26.72
    Particulars MAR 2024 (Values in Cr)
    Revenue 709.26
    Operating Expense 647.39
    Net Profit 49.42
    Net Profit Margin (%) 6.96
    Earnings Per Share (EPS) 5.84
    EBITDA 121.30
    Effective Tax Rate (%) 25.49
    Particulars MAR 2023 (Values in Cr)
    Revenue 522.05
    Operating Expense 521.41
    Net Profit 4.08
    Net Profit Margin (%) 0.78
    Earnings Per Share (EPS) 0.48
    EBITDA 59.59
    Effective Tax Rate (%) 26.48
    Particulars MAR 2022 (Values in Cr)
    Revenue 519.87
    Operating Expense 456.42
    Net Profit 68.04
    Net Profit Margin (%) 13.08
    Earnings Per Share (EPS) 8.04
    EBITDA 119.68
    Effective Tax Rate (%) 0.90
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 70.36
    ROE % 11.46
    ROCE % 12.53
    Total Debt to Total Equity 0.50
    EBITDA Margin 17.38
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 59.98
    ROE % 9.87
    ROCE % 11.69
    Total Debt to Total Equity 0.54
    EBITDA Margin 16.11
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 54.40
    ROE % 0.83
    ROCE % 3.77
    Total Debt to Total Equity 0.56
    EBITDA Margin 10.72
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 55.56
    ROE % 15.41
    ROCE % 12.50
    Total Debt to Total Equity 0.59
    EBITDA Margin 21.57
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 48.50
    ROE % 16.07
    ROCE % 17.43
    Total Debt to Total Equity 0.54
    EBITDA Margin 20.37
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 74.13
    ROE % 11.00
    ROCE % 12.18
    Total Debt to Total Equity 0.48
    EBITDA Margin 17.50
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 64.02
    ROE % 9.28
    ROCE % 11.22
    Total Debt to Total Equity 0.50
    EBITDA Margin 16.14
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 58.49
    ROE % 0.83
    ROCE % 3.65
    Total Debt to Total Equity 0.52
    EBITDA Margin 10.76
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 58.33
    ROE % 14.76
    ROCE % 12.17
    Total Debt to Total Equity 0.56
    EBITDA Margin 21.60
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 50.59
    ROE % 15.32
    ROCE % 16.90
    Total Debt to Total Equity 0.52
    EBITDA Margin 20.37
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 41.58
    Total Assets 1152.68
    Total Liabilities 1152.68
    Total Equity 639.64
    Share Outstanding 8
    Price to Book Ratio 2.87
    Return on Assets (%) 5.99
    Return on Capital (%) 7.27
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 36.20
    Total Assets 1034.09
    Total Liabilities 1034.09
    Total Equity 536.32
    Share Outstanding 8
    Price to Book Ratio 2.78
    Return on Assets (%) 4.81
    Return on Capital (%) 6.1
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 7.46
    Total Assets 879.61
    Total Liabilities 879.61
    Total Equity 460.52
    Share Outstanding 8
    Price to Book Ratio 0.99
    Return on Assets (%) -0.80
    Return on Capital (%) -0.99
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 46.66
    Total Assets 859.50
    Total Liabilities 859.50
    Total Equity 470.28
    Share Outstanding 8
    Price to Book Ratio 1.61
    Return on Assets (%) 7.23
    Return on Capital (%) 8.52
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 40.50
    Total Assets 812.21
    Total Liabilities 812.21
    Total Equity 410.52
    Share Outstanding 8
    Price to Book Ratio 2.46
    Return on Assets (%) 7.69
    Return on Capital (%) 9.46
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 41.57
    Total Assets 1186.10
    Total Liabilities 1186.10
    Total Equity 673.06
    Share Outstanding 8
    Price to Book Ratio 2.87
    Return on Assets (%) 5.76
    Return on Capital (%) 6.95
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 36.20
    Total Assets 1068.25
    Total Liabilities 1068.25
    Total Equity 570.48
    Share Outstanding 8
    Price to Book Ratio 2.78
    Return on Assets (%) 4.62
    Return on Capital (%) 5.81
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 7.46
    Total Assets 914.18
    Total Liabilities 914.18
    Total Equity 495.09
    Share Outstanding 8
    Price to Book Ratio 0.99
    Return on Assets (%) 0.44
    Return on Capital (%) 0.55
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 46.66
    Total Assets 882.97
    Total Liabilities 882.97
    Total Equity 493.76
    Share Outstanding 8
    Price to Book Ratio 1.61
    Return on Assets (%) 7.70
    Return on Capital (%) 9.02
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 40.50
    Total Assets 829.90
    Total Liabilities 829.90
    Total Equity 428.22
    Share Outstanding 8
    Price to Book Ratio 2.46
    Return on Assets (%) 7.34
    Return on Capital (%) 8.98
    Particulars MAR 2025 (Values in Cr)
    Net Income 92.33
    Cash from Operations 101.54
    Cash from Investing -123.42
    Cash from Financing 47.07
    Net change in Cash 5.35
    Free Cash Flow 224.92
    Particulars MAR 2024 (Values in Cr)
    Net Income 66.10
    Cash from Operations 65.52
    Cash from Investing -52.07
    Cash from Financing 30.67
    Net change in Cash 28.73
    Free Cash Flow 117.68
    Particulars MAR 2023 (Values in Cr)
    Net Income 5.34
    Cash from Operations 27.05
    Cash from Investing -29.75
    Cash from Financing -31.96
    Net change in Cash -39.27
    Free Cash Flow 56.97
    Particulars MAR 2022 (Values in Cr)
    Net Income 68.49
    Cash from Operations 59.98
    Cash from Investing -27.15
    Cash from Financing -11.74
    Net change in Cash 6.15
    Free Cash Flow 87.22
    Particulars MAR 2021 (Values in Cr)
    Net Income 91.11
    Cash from Operations 106.49
    Cash from Investing -151.59
    Cash from Financing 92.01
    Net change in Cash 30.87
    Free Cash Flow 258.24
    Particulars MAR 2025 (Values in Cr)
    Net Income 93.32
    Cash from Operations 101.54
    Cash from Investing -123.43
    Cash from Financing 47.07
    Net change in Cash 5.35
    Free Cash Flow 224.92
    Particulars MAR 2024 (Values in Cr)
    Net Income 66.33
    Cash from Operations 65.52
    Cash from Investing -52.07
    Cash from Financing 30.67
    Net change in Cash 28.73
    Free Cash Flow 117.68
    Particulars MAR 2023 (Values in Cr)
    Net Income 5.54
    Cash from Operations 27.05
    Cash from Investing -29.75
    Cash from Financing -31.96
    Net change in Cash -39.27
    Free Cash Flow 56.97
    Particulars MAR 2022 (Values in Cr)
    Net Income 68.65
    Cash from Operations 59.98
    Cash from Investing -27.15
    Cash from Financing -11.74
    Net change in Cash 6.15
    Free Cash Flow 87.22
    Particulars MAR 2021 (Values in Cr)
    Net Income 91.11
    Cash from Operations 106.49
    Cash from Investing -151.59
    Cash from Financing 92.01
    Net change in Cash 30.87
    Free Cash Flow 258.24
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.72 13.52 1.58 250.74 23.12 38.85
    BLISS GVS PHARMA LTD 506.15 40.69 4.49 5368.04 118.35 552.90
    CIPLA LTD. 1458.45 30.95 3.42 117820.20 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 345.85 15.26 2.50 1017.87 256.40 399.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.72 22.88 4.21 250.74 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 536.85 24.06 4.19 1552.07 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8297.90 108.37 23.76 20744.75 7630.00 9850.00
    BLISS GVS PHARMA LTD 506.15 54.72 4.64 5368.04 118.35 552.90

    SMS PHARMACEUTICALS LTD. shareholding pattern

    Holding
    28.6%
    68.06%
    0.3%
    3.02%
    17.99%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    SMS PHARMACEUTICALS LTD. Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    421.45 0.90 redarrow
    red-green-graph indicator
    0 Bearish
    16 Bullish
    • 5 Days 409.20
    • 26 Days 389.50
    • 10 Days 398.90
    • 50 Days 387.70
    • 12 Days 396.30
    • 100 Days 376.60
    • 20 Days 390.90
    • 200 Days 349.40
    416.17 PIVOT
    First Support 408.18 First Resistance 425.63 Second Support 398.72 Second Resistance 433.62 Third Support 390.73 Third Resistance 443.08
    RSI 68.10 ADX 42.36 MACD 6.75 Williams % R -24.80 Commodity Channel Index (CCI) 192.57
    Date 2026-07-03 Week 270828.00 Same Day 86621.00 Month 113538.00
    1 Year 1.28 3 Year 1.10
    Over 1 Month
    18.21% down
    Over 1 Year
    74.73% down
    Over 3 Months
    7.91% down
    Over 3 Years
    66.08% down
    Over 6 Months
    25.54% down
    Over 5 Years
    18.63% down

    SMS PHARMACEUTICALS LTD. Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    22 Sep 2025 0.4 Final 22 Sep 2025 Equity shares
    23 Sep 2024 0.4 Final 23 Sep 2024 Equity shares
    22 Sep 2023 0.3 Final 22 Sep 2023 Equity shares
    22 Sep 2022 0.3 Final 23 Sep 2022 Equity shares
    22 Sep 2021 0.3 Final 24 Sep 2021 Equity shares
    26 Mar 2020 0.25 Interim 28 Mar 2020 Equity shares
    19 Sep 2019 0.25 Final 23 Sep 2019 Equity shares
    11 Sep 2018 0.25 Final 13 Sep 2018 Equity shares
    20 Sep 2017 0.2 Final 22 Sep 2017 Equity shares
    22 Sep 2016 0.2 Final 24 Sep 2016 Equity shares
    22 Sep 2015 2.0 Final 24 Sep 2015 Equity shares
    23 Sep 2014 2.0 Final 25 Sep 2014 Equity shares
    23 Sep 2013 2.0 Final 25 Sep 2013 Equity shares
    22 Sep 2011 1.5 Final 24 Sep 2011 Equity shares
    23 Sep 2010 1.0 Final 25 Sep 2010 Equity shares
    23 Sep 2009 2.0 Final 25 Sep 2009 Equity shares
    23 Dec 2008 2.0 Final 26 Dec 2008 Equity shares
    21 Sep 2007 2.0 Final 25 Sep 2007 Equity shares
    Ex-Date Old FV NEW FV Record Date
    17 Dec 2015 10.0 1.0 18 Dec 2015
    Dividend date Dividend amount Dividend type Record date Instrument type
    22 Sep 2025 0.4 Final 22 Sep 2025 Equity shares
    23 Sep 2024 0.4 Final 23 Sep 2024 Equity shares
    22 Sep 2023 0.3 Final 22 Sep 2023 Equity shares
    22 Sep 2022 0.3 Final 23 Sep 2022 Equity shares
    22 Sep 2021 0.3 Final 24 Sep 2021 Equity shares
    26 Mar 2020 0.25 Interim 28 Mar 2020 Equity shares
    19 Sep 2019 0.25 Final 23 Sep 2019 Equity shares
    11 Sep 2018 0.25 Final 13 Sep 2018 Equity shares
    20 Sep 2017 0.2 Final 22 Sep 2017 Equity shares
    22 Sep 2016 0.2 Final 24 Sep 2016 Equity shares
    22 Sep 2015 2.0 Final 24 Sep 2015 Equity shares
    23 Sep 2014 2.0 Final 25 Sep 2014 Equity shares
    23 Sep 2013 2.0 Final 25 Sep 2013 Equity shares
    22 Sep 2011 1.5 Final 24 Sep 2011 Equity shares
    23 Sep 2010 1.0 Final 25 Sep 2010 Equity shares
    23 Sep 2009 2.0 Final 25 Sep 2009 Equity shares
    23 Dec 2008 2.0 Final 26 Dec 2008 Equity shares
    21 Sep 2007 2.0 Final 25 Sep 2007 Equity shares
    Ex-Date Old FV NEW FV Record Date
    17 Dec 2015 10.0 1.0 18 Dec 2015

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of SMS Pharmaceuticals Ltd?

    Answer Field

    SMS Pharmaceuticals Ltd share price is for NSE ₹ 421.45 & for BSE ₹ 424.50 as on Jul 03 2026 03:30 PM.

    What is the Market Cap of SMS Pharmaceuticals Ltd Share?

    Answer Field

    The market cap of SMS Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 03 2026 03:30 PM.

    What is the 52 Week High and Low of SMS Pharmaceuticals Ltd?

    Answer Field

    The 52 Week High and Low of SMS Pharmaceuticals Ltd for NSE is ₹ 447.80 and ₹ 207.99 and for BSE is ₹ 446.50 and ₹ 208.20.

    What is 1 year return for SMS Pharmaceuticals Ltd?

    Answer Field

    The 1 year returns on the stock has been 74.73%.

    What is the P/E Ratio of SMS Pharmaceuticals Ltd Share?

    Answer Field

    As on Jul 03 2026 03:30 PM the price-to-earnings (PE) ratio for SMS Pharmaceuticals Ltd share is 45.09.

    What is the PB ratio of SMS Pharmaceuticals Ltd Share?

    Answer Field

    As on Jul 03 2026 03:30 PM, the price-to-book (PB) ratio for SMS Pharmaceuticals Ltd share is 85.93.

    How to Buy SMS Pharmaceuticals Ltd Share?

    Answer Field

    You can trade in SMS Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy SMS Pharmaceuticals Ltd Share on Bajaj Broking App?

    Answer Field

    To buy SMS Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “SMS Pharmaceuticals Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |